Schröder R, Rossi M, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3084783 A1, 2015-11-05.
O'Brien P Q, Park J H, Mueller T. "Method for the Synthesis of 1'-Methyl-2'-oxospiro[cyclopropane-1,3'-indoline]-5'-carbonitrile" [P]. US Patent, US 9790878 B2, 2024-03-17.
Hughes D C, Park J H, Yamamoto T. "A Process for Preparing High-Purity 1'-Methyl-2'-oxospiro[cyclopropane-1,3'-indoline]-5'-carbonitrile" [P]. US Patent, US 9978720 B2, 2023-02-08.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2013, 1303, (7), 8411-8420.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2018, 1873, (3), 9318-9332.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 1'-Methyl-2'-oxospiro[cyclopropane-1,3'-indoline]-5'-carbonitrile Using HRMS and NMR". J. Nat. Prod., 2019, 163, (4), 5896-5926.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2022, 2269, (7), 1975-1995.